Equity Analysis

Quarterly Results

    RPG Life Sciences Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    532983
    INE105J01010
    229.3856146
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    RPGLIFE
    44.65
    3888.07
    EPS(TTM)
    Face Value()
    Div & Yield %:
    52.65
    8
    0.68
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales172.21165.42126.99
Other Operating Income0.000.000.00
Other Income 1.942.371.65
Total Income174.15167.79128.64
Total Expenditure 153.58126.35106.27
PBIDT20.5741.4422.37
Interest 0.170.150.14
PBDT20.4041.2922.23
Depreciation5.315.294.49
Tax10.789.515.45
Fringe Benefit Tax0.000.000.00
Deferred Tax0.11-0.27-0.95
Reported Profit After Tax4.2026.7613.24
Extra-ordinary Items -16.410.000.00
Adjusted Profit After Extra-ordinary item20.6126.7613.24
EPS (Unit Curr.)2.5416.188.01
EPS (Adj) (Unit Curr.)2.5416.188.01
Calculated EPS (Unit Curr.)2.5416.188.01
Calculated EPS (Adj) (Unit Curr.)2.5416.188.01
Calculated EPS (Ann.) (Unit Curr.)10.1664.7332.02
Calculated EPS (Adj) (Ann.) (Unit Curr.)10.1664.7332.02
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity13.2313.2313.23
Reserve & Surplus0.000.000.00
Face Value8.008.008.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)11.9425.0517.62
PBDTM(%)11.8524.9617.51
PATM(%)2.4416.1810.43
Dividend Per Share(Rs)0.000.000.00
Diluted EPS2.5416.188.01